Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study

BACKGROUND: Genetic risk factors for chemotherapy-induced peripheral neuropathy (CIPN), a major dose-limiting side-effect of paclitaxel, are not well understood. METHODS: We performed a genome-wide association study (GWAS) in 183 paclitaxel-treated patients to identify genetic loci associated with C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooshmand, Kosar, Goldstein, David, Timmins, Hannah C., Li, Tiffany, Harrison, Michelle, Friedlander, Michael L., Lewis, Craig R., Lees, Justin G., Moalem-Taylor, Gila, Guennewig, Boris, Park, Susanna B., Kwok, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724416/
https://www.ncbi.nlm.nih.gov/pubmed/36474270
http://dx.doi.org/10.1186/s12967-022-03754-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724416/
https://www.ncbi.nlm.nih.gov/pubmed/36474270
http://dx.doi.org/10.1186/s12967-022-03754-4

Ejemplares similares